Pages that link to "Q33987654"
Jump to navigation
Jump to search
The following pages link to Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients (Q33987654):
Displaying 39 items.
- Targeting the Brain Reservoirs: Toward an HIV Cure (Q28075694) (← links)
- The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit (Q28535156) (← links)
- The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study (Q28541478) (← links)
- Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals (Q33917180) (← links)
- Risk of all-cause mortality in HIV infected patients is associated with clinical, immunologic predictors and the CCR5 Δ32 deletion (Q33971366) (← links)
- Residual immune dysregulation syndrome in treated HIV infection (Q34020121) (← links)
- Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants (Q34255703) (← links)
- Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort study (Q34554118) (← links)
- Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America (Q34736194) (← links)
- When to start antiretroviral therapy: the need for an evidence base during early HIV infection (Q34773308) (← links)
- Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis (Q35180503) (← links)
- Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort (Q35215672) (← links)
- Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study (Q35806035) (← links)
- Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings (Q35905907) (← links)
- The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHOD (Q35916153) (← links)
- HIV infection and coronary heart disease: an intersection of epidemics (Q35949941) (← links)
- Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy (Q36015621) (← links)
- Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? (Q36338387) (← links)
- Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care (Q36492436) (← links)
- Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. (Q36937890) (← links)
- Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy (Q37207042) (← links)
- High risk of obesity and weight gain for HIV-infected uninsured minorities (Q37642702) (← links)
- RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS). (Q37662724) (← links)
- Renal issues in HIV infection (Q37885232) (← links)
- Management of fat accumulation in patients with HIV infection (Q37899071) (← links)
- Considerations for Endpoint Selection When Designing HIV Clinical Trials (Q37967498) (← links)
- Achieving a cure for HIV infection: do we have reasons to be optimistic? (Q37980423) (← links)
- Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival (Q37989867) (← links)
- Epidemiology of ischemic heart disease in HIV. (Q38629009) (← links)
- Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia (Q39550582) (← links)
- Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach (Q40060299) (← links)
- Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial (Q40150734) (← links)
- Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy (Q40954848) (← links)
- Late diagnosis of human immunodeficiency virus infection in patients with viral hepatitis. (Q45350855) (← links)
- Kidney Disease in HIV-Infected Persons (Q46653347) (← links)
- All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration (Q47918470) (← links)
- Serious Non-AIDS Conditions in HIV: Benefit of Early ART. (Q51418317) (← links)
- British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (Q57180790) (← links)
- Race and CD4+T-cell count in HIV prognosis and treatment (Q58033132) (← links)